Bifidobacterium Beneficial Reduced in Irritable bowel syndrome (IBS)
Genus
Commonly lower in IBS and a frequent probiotic target, though effect sizes vary widely.
Moderate evidence source: curated sample
Commonly lower in IBS and a frequent probiotic target, though effect sizes vary widely.
This methane-producing archaeon is enriched in constipation-predominant IBS and linked to slower transit.
The contested one: linked to IBS in some studies, yet associated with healthier, high-diversity guts in asymptomatic carriers. Many IBS patients don’t carry it at all.